These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8442236)

  • 1. Cadaveric kidney exchange on the basis of HLA-matching is already cost-effective in the first year after grafting.
    Christiaans MH; van den Berg-Loonen PM; Nieman FH; Cohen B; Kootstra G; van Hooff JP
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1685-6. PubMed ID: 8442236
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy.
    Taylor CJ; Bayne AM; Welsh KI; Morris PJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):210-1. PubMed ID: 8438273
    [No Abstract]   [Full Text] [Related]  

  • 3. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression.
    Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D
    Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of HLA matching in kidney transplants: 30 years after.
    Belzer FO
    Clin Transpl; 1993; ():426-7. PubMed ID: 7918174
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades.
    Opelz G; Döhler B
    Transplantation; 2007 Jul; 84(2):137-43. PubMed ID: 17667803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications.
    Doxiadis II; Smits JM; Stobbe I; Schreuder GM; Persijn GG; van Houwelingen H; van Rood JJ; Claas FH
    Transplant Proc; 1996 Feb; 28(1):224. PubMed ID: 8644189
    [No Abstract]   [Full Text] [Related]  

  • 9. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HLA and rejection of renal transplants from cadavers].
    Zanuso C; Pontiero P; Ancona G; Muolo A; Confortini P
    Minerva Chir; 1980 May; 35(10):793-5. PubMed ID: 7005737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of repeated HLA mismatches on the outcome of renal allograft retransplantation.
    Povlsen JV; Madsen M; Birkeland SA; Løkkegaard H; Pedersen EB; Svejgaard A; Olgaard K; Fjeldborg O
    Transplant Proc; 1992 Feb; 24(1):307-8. PubMed ID: 1539288
    [No Abstract]   [Full Text] [Related]  

  • 14. Kidney graft survival, clinical course, and HLA-A, B, and D matching in 208 patients transplanted in one center.
    van Hooff JP; van Hooff-Eijkenboom YE; Kalff MW; de Graeff J; van Rood JJ
    Transplant Proc; 1979 Jun; 11(2):1291-2. PubMed ID: 382514
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevation of serum C-reactive protein levels during graft rejection.
    Lempert N; Laffin RJ; Fitzgerald K; Freed BM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1683-5. PubMed ID: 3274404
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of mismatching of HLA cross-reactive groups on cadaveric kidney transplantation.
    Hwang SH; Oh HB; Shin ES; Yew M; Kim SC; Han DJ
    Transplant Proc; 2005 Dec; 37(10):4194-8. PubMed ID: 16387076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bw4/Bw6 matching and renal allograft survival in homozygous recipients.
    Spreng WM; Nathan P; First MR
    Proc Clin Dial Transplant Forum; 1979; 9():93-4. PubMed ID: 399520
    [No Abstract]   [Full Text] [Related]  

  • 18. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
    Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of HLA matching on kidney allograft survival.
    Suciu-Foca N; Cohen DJ; Benvenisty AI; Benstein JA; Reed EF; Ho E; Hardy MA
    Transplant Proc; 1996 Feb; 28(1):121-2. PubMed ID: 8644140
    [No Abstract]   [Full Text] [Related]  

  • 20. Strong impact of HLA-DR-matching on graft survival in 413 consecutive cadaver kidney transplants performed in Copenhagen over an eight-year period.
    Jakobsen BK; Ryder LP; Ladefoged J; Løkkegaard H; Nielsen B; Olgaard K; Svejgaard A
    Transplant Proc; 1995 Dec; 27(6):3452-3. PubMed ID: 8540048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.